These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35356464)

  • 1. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
    Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
    PeerJ; 2022; 10():e13057. PubMed ID: 35356464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
    Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
    [No Abstract]   [Full Text] [Related]  

  • 3. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
    BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
    Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA.
    Han Y; Dong Z; Xing Y; Zhan Y; Zou J; Wang X
    BMC Pulm Med; 2023 Dec; 23(1):511. PubMed ID: 38102594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
    Wang W; Wang S; Chu X; Liu H; Xiang M
    J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
    Luo Y; Xuan Z; Zhu X; Zhan P; Wang Z
    Mol Med Rep; 2018 May; 17(5):7238-7248. PubMed ID: 29568882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
    Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
    BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
    Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
    BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
    Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
    J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Wang W; Cui G; Zhao S
    Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
    Wang K; Li Y; Wang J; Chen R; Li J
    Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.
    Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H
    Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
    Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
    Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
    Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
    Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
    Lee N; Xia X; Meng H; Zhu W; Wang X; Zhang T; Zhang C; Zhang J; Luo P
    Cancer Biomark; 2021; 30(1):63-73. PubMed ID: 32924987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.